Renal biochemistry in rheumatic disease

Area of Science:

• Nephrology
• Rheumatology
• Internal Medicine

Background:

• Osteoarthritis typically involves coincidental renal pathology, not direct disease consequence.
• Rheumatoid arthritis and ankylosing spondylitis can lead to renal disease through systemic pathology or treatment side effects.
• Amyloidosis is a significant complication causing irreversible renal function loss in some polyarthritic conditions.

Purpose of the Study:

• To differentiate causes of renal disease in various arthritic conditions.
• To highlight the increased renal risk associated with specific systemic autoimmune diseases.
• To emphasize the importance of early renal function evaluation in at-risk patients.

Main Methods:

• Review of renal pathology in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
• Comparative analysis of renal involvement in systemic lupus erythematosus, polyarteritis, and Sjögren's disease.
• Discussion of diagnostic and monitoring strategies for renal complications.

Main Results:

• Renal disease in osteoarthritis is generally unrelated to the arthritis itself.
• Rheumatoid arthritis and ankylosing spondylitis present risks of renal disease, with amyloidosis being a key concern for progressive loss of function.
• Systemic lupus erythematosus, polyarteritis, and Sjögren's disease demonstrate a substantially higher risk of renal involvement.

Conclusions:

• Early and regular assessment of renal function is crucial for patients with specific rheumatic and systemic diseases.
• Timely intervention based on early detection of kidney damage can help manage progressive renal disease.
• Understanding the distinct patterns of renal involvement aids in risk stratification and patient management.